Goldman Sachs analyst Lisa Deng initiated coverage of Sigma Healthcare (SIGGF) with a Neutral rating and A$2.70 price target The firm views Sigma as a vertically integrated retail pharmacy leader with scaled cost and franchise advantages.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SIGGF:
- Sigma Healthcare Announces Strategic Merger to Enhance Growth
- Sigma Healthcare Ltd Announces Quotation of New Securities on ASX
- State Street Corporation Reduces Holdings in Sigma Healthcare
- Sigma Healthcare Ltd Announces Quotation of New Securities
- Sigma Healthcare Announces Director’s Securities Restructuring